A randomized open-label controlled clinical study to evaluate the efficacy of vriddhadaru rasayana in mild cognitive impairment of the elderly.

Dr Ananyalakshmi E0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年8月2日

试验速览

暂无简介。

•1. Subjects who get score less than 26 in moca and less than 24 in mmse scale.
•2. Subjects willing to participate with written informed consent which is conveyed in the language which the subject can understand.

•1. Subjects who have lost cognitive function as a result of trauma
•2. Subjects with tumor types of dementia like alzheimers dementia, vascular dementia, lewybody dementia etc and lost cognitive function as a result of these.
•3. Subjects with uncontrolled systemic illness including diabetes mellitus and hypertension.
•4. Subjects under anti psychotic drugs, anti epileptic drugs.
•5. Subjects having any other conditions which can interfere with the treatment.

发起方

Dr Ananyalakshmi E